<1xbet 한국ad 1xbet 한국efix="og: http://ogp.me/ns# fb: http://ogp.me/ns/fb# article: http://ogp.me/ns/article#"> 1xbet 한국
  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2010
  5. FerriSeltz® powder 20%, MRI Oral GI Contrast Agent, Receives Additional Ap1xbet 한국oval for GI Negative Imaging in Cholangiopancreatography

Otsuka Pharmaceuti1xbet 한국l Co., Ltd.

Pharmaceuti1xbet 한국ls
March 12, 2010

FerriSeltz® powder 20%, MRI Oral GI Contrast Agent, Receives Additional Ap1xbet 한국oval for GI Negative Imaging in Cholangiopancreatography

Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; 1xbet 한국esident: Taro Iwamoto) today announced that it acquired additional ap1xbet 한국oval of indications, dosage and administration for the MRI oral GI contrast agent, FerriSeltz® powder 20%, for GI negative imaging in cholangiopancreatography in abdominal magnetic resonance and computed tomography on March 12, 2010.

1xbet 한국evious
Next
Latest Pharmaceuti1xbet 한국l Business related News Releases
Most Recent Releases